LPL and non-small cell lung carcinoma: In non-small-cell lung cancer (NSCLC) tumor cells, enzymes such as lipoprotein lipase (LPL) are known to use triacylglycerols (TAGs) and phospholipids (PLs) from the bloodstream to acquire energy for membrane synthesis and tumor proliferation via lipolysis [70,71].